CSafe key facts
- Manufacturer of cold chain equipment designed for the pharmaceutical, biotechnology, military, airlines, and logistics industries.
- It has raised $377.1M; the latest was PE Growth/Expansion in Feb 2026.
- Notable investors include Frazier Healthcare Partners, British Columbia Investment Management, Future Standard (Philadelphia), Thomas H. Lee Partners.
- Status: Privately Held (backing).
- ·Watch CSafe: the Monday email on marks, rounds and moves
CSafe funding rounds
No funding rounds for CSafe are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CSafe investors
4 investors are on record for CSafe, including Frazier Healthcare Partners, British Columbia Investment Management, Future Standard (Philadelphia) and Thomas H. Lee Partners.
About CSafe
Manufacturer of cold chain equipment designed for the pharmaceutical, biotechnology, military, airlines, and logistics industries. The company offers active air cargo services, passive parcels, cell and gene services, mobile refrigeration units, and temperature-sensitive bio-pharmaceutical cargo, enabling clients to address global supply chain needs while transporting goods at the required temperature.
- Sector
- Business Products and Services (B2B)
- HQ
- Monroe, OH, United States
- Founded
- 1979
- Employees
- 134
- Website
- csafeglobal.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
CSafe doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.